168 related articles for article (PubMed ID: 35406647)
1. Lichen Secondary Metabolites Inhibit the Wnt/β-Catenin Pathway in Glioblastoma Cells and Improve the Anticancer Effects of Temozolomide.
Majchrzak-Celińska A; Kleszcz R; Studzińska-Sroka E; Łukaszyk A; Szoszkiewicz A; Stelcer E; Jopek K; Rucinski M; Cielecka-Piontek J; Krajka-Kuźniak V
Cells; 2022 Mar; 11(7):. PubMed ID: 35406647
[TBL] [Abstract][Full Text] [Related]
2. Lichen-derived caperatic acid and physodic acid inhibit Wnt signaling in colorectal cancer cells.
Paluszczak J; Kleszcz R; Studzińska-Sroka E; Krajka-Kuźniak V
Mol Cell Biochem; 2018 Apr; 441(1-2):109-124. PubMed ID: 28887754
[TBL] [Abstract][Full Text] [Related]
3. COXIBs and 2,5-dimethylcelecoxib counteract the hyperactivated Wnt/β-catenin pathway and COX-2/PGE2/EP4 signaling in glioblastoma cells.
Majchrzak-Celińska A; Misiorek JO; Kruhlenia N; Przybyl L; Kleszcz R; Rolle K; Krajka-Kuźniak V
BMC Cancer; 2021 May; 21(1):493. PubMed ID: 33941107
[TBL] [Abstract][Full Text] [Related]
4. miR-126-3p sensitizes glioblastoma cells to temozolomide by inactivating Wnt/β-catenin signaling via targeting SOX2.
Luo W; Yan D; Song Z; Zhu X; Liu X; Li X; Zhao S
Life Sci; 2019 Jun; 226():98-106. PubMed ID: 30980849
[TBL] [Abstract][Full Text] [Related]
5. Modulating Wnt/β-Catenin Signaling Pathway on U251 and T98G Glioblastoma Cell Lines Using a Combination of Paclitaxel and Temozolomide, A Molecular Docking Simulations and Gene Expression Study.
Jamalpour S; Alinezhad A; Sabah JT; Vazifehmand R; Behrooz AB; Hamzah ASA; Davazdahemami AA; Homaie FM; Maddah SM
Chem Pharm Bull (Tokyo); 2023; 71(10):766-774. PubMed ID: 37779078
[TBL] [Abstract][Full Text] [Related]
6. Methoxy-stilbenes downregulate the transcription of Wnt/β-catenin-dependent genes and lead to cell cycle arrest and apoptosis in human T98G glioblastoma cells.
Majchrzak-Celińska A; Zielińska-Przyjemska M; Wierzchowski M; Kleszcz R; Studzińska-Sroka E; Kaczmarek M; Paluszczak J; Cielecka-Piontek J; Krajka-Kuźniak V
Adv Med Sci; 2021 Mar; 66(1):6-20. PubMed ID: 33238230
[TBL] [Abstract][Full Text] [Related]
7. LINC00511 facilitates Temozolomide resistance of glioblastoma cells via sponging miR-126-5p and activating Wnt/β-catenin signaling.
Lu Y; Tian M; Liu J; Wang K
J Biochem Mol Toxicol; 2021 Sep; 35(9):e22848. PubMed ID: 34328678
[TBL] [Abstract][Full Text] [Related]
8. Sulforaphane enhances temozolomide-induced apoptosis because of down-regulation of miR-21 via Wnt/β-catenin signaling in glioblastoma.
Lan F; Pan Q; Yu H; Yue X
J Neurochem; 2015 Sep; 134(5):811-8. PubMed ID: 25991372
[TBL] [Abstract][Full Text] [Related]
9. Wnt/β-catenin signaling pathway induces autophagy-mediated temozolomide-resistance in human glioblastoma.
Yun EJ; Kim S; Hsieh JT; Baek ST
Cell Death Dis; 2020 Sep; 11(9):771. PubMed ID: 32943609
[TBL] [Abstract][Full Text] [Related]
10. 20(S)-ginsenoside-Rg3 reverses temozolomide resistance and restrains epithelial-mesenchymal transition progression in glioblastoma.
Chen Z; Wei X; Shen L; Zhu H; Zheng X
Cancer Sci; 2019 Jan; 110(1):389-400. PubMed ID: 30431207
[TBL] [Abstract][Full Text] [Related]
11. Wnt/β-catenin Antagonists: Exploring New Avenues to Trigger Old Drugs in Alleviating Glioblastoma Multiforme.
Precilla DS; Kuduvalli SS; Purushothaman M; Marimuthu P; Muralidharan AR; Anitha TS
Curr Mol Pharmacol; 2022; 15(2):338-360. PubMed ID: 33881978
[TBL] [Abstract][Full Text] [Related]
12. Up-Regulation of Cyclooxygenase-2 (COX-2) Expression by Temozolomide (TMZ) in Human Glioblastoma (GBM) Cell Lines.
Lombardi F; Augello FR; Artone S; Gugu MK; Cifone MG; Cinque B; Palumbo P
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163465
[TBL] [Abstract][Full Text] [Related]
13. Lichen-Derived Depsides and Depsidones Modulate the Nrf2, NF-κB and STAT3 Signaling Pathways in Colorectal Cancer Cells.
Papierska K; Krajka-Kuźniak V; Paluszczak J; Kleszcz R; Skalski M; Studzińska-Sroka E; Baer-Dubowska W
Molecules; 2021 Aug; 26(16):. PubMed ID: 34443375
[TBL] [Abstract][Full Text] [Related]
14. Temozolomide induces activation of Wnt/β-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy.
Tomar VS; Patil V; Somasundaram K
Cell Biol Toxicol; 2020 Jun; 36(3):273-278. PubMed ID: 31758290
[TBL] [Abstract][Full Text] [Related]
15. In vitro antitumor activities of the lichen compounds olivetoric, physodic and psoromic acid in rat neuron and glioblastoma cells.
Emsen B; Aslan A; Togar B; Turkez H
Pharm Biol; 2016 Sep; 54(9):1748-62. PubMed ID: 26704132
[TBL] [Abstract][Full Text] [Related]
16. Combination Therapy with Nanomicellar-Curcumin and Temozolomide for In Vitro Therapy of Glioblastoma Multiforme via Wnt Signaling Pathways.
Bagherian A; Mardani R; Roudi B; Taghizadeh M; Banfshe HR; Ghaderi A; Davoodvandi A; Shamollaghamsari S; Hamblin MR; Mirzaei H
J Mol Neurosci; 2020 Oct; 70(10):1471-1483. PubMed ID: 32666415
[TBL] [Abstract][Full Text] [Related]
17. 5-lipoxygenase as a target to sensitize glioblastoma to temozolomide treatment via β-catenin-dependent pathway.
Tang D; Hu Y; Gao W
Neurol Res; 2023 Nov; 45(11):1026-1034. PubMed ID: 37695758
[TBL] [Abstract][Full Text] [Related]
18. Sodium Butyrate Enhances Curcuminoids Permeability through the Blood-Brain Barrier, Restores Wnt/β-Catenin Pathway Antagonists Gene Expression and Reduces the Viability of Glioblastoma Cells.
Majchrzak-Celińska A; Kleszcz R; Stasiłowicz-Krzemień A; Cielecka-Piontek J
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681943
[TBL] [Abstract][Full Text] [Related]
19. NBM-BMX, an HDAC8 Inhibitor, Overcomes Temozolomide Resistance in Glioblastoma Multiforme by Downregulating the β-Catenin/c-Myc/SOX2 Pathway and Upregulating p53-Mediated MGMT Inhibition.
Tsai CY; Ko HJ; Chiou SJ; Lai YL; Hou CC; Javaria T; Huang ZY; Cheng TS; Hsu TI; Chuang JY; Kwan AL; Chuang TH; Huang CF; Loh JK; Hong YR
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072831
[TBL] [Abstract][Full Text] [Related]
20. Lichen-Derived Compounds and Extracts as Biologically Active Substances with Anticancer and Neuroprotective Properties.
Studzińska-Sroka E; Majchrzak-Celińska A; Zalewski P; Szwajgier D; Baranowska-Wójcik E; Kaproń B; Plech T; Żarowski M; Cielecka-Piontek J
Pharmaceuticals (Basel); 2021 Dec; 14(12):. PubMed ID: 34959693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
